Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MGC Diagnostics Corp (NASDAQ:MGCD)

Delayed Data
As of 3:10pm ET
 +0.1976 / +3.16%
Today’s Change
Today|||52-Week Range
Health Technology
Medical Specialties

Company Description

MGC Diagnostics Corp. operates as a medical technology company dedicated to cardio respiratory health solutions. The company designs, markets and sells non-invasive cardio respiratory diagnostic products through its medical graphics corporation subsidiary under the MGC diagnostics brand and trade name. MGC diagnostics sells its products internationally through distributors and in the United States through a direct sales force targeting specialists located in hospitals, university based medical centers, medical clinics, physician offices, pharmaceutical companies, medical device manufacturers, and clinical research organizations. Its cardiorespiratory diagnostic products have a common functional testing platform the measurement of air flow and respiratory pressures and, in most cases, the analysis of inhaled and exhaled gases such as oxygen and carbon dioxide. MGC Diagnostics was founded in May 1986 and is headquartered in St. Paul, MN.

Contact Information

MGC Diagnostics Corp.
350 Oak Grove Parkway
St. Paul Minnesota 55127-8599
P:(651) 484-4874
Investor Relations:
(651) 766-3497



Individual stakeholders9.78%
Mutual fund holders3.37%
Other institutional17.02%

Top Executives

Todd M. AustinChief Executive Officer
Matthew S. MargoliesPresident
Wesley W. WinnekinsCOO, CFO, Secretary & Head-Investor Relations
Mark T. GryzwaVice President-Engineering